Axonics (AXNX) News Today

Sei Investments Co. cut its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 68.2% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 33,597 shares of the company's stock after selling 71,992 shares dur

Edgestream Partners L.P. acquired a new position in Axonics, Inc. (NASDAQ:AXNX - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 8,767 shares of the company's stock, valued at approxi

Scout Investments Inc. decreased its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 33.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 62,507 shares of the company's stock after selling 3

Entropy Technologies LP acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 9,025 shares of the company's stock, valued at appro

BNP Paribas Financial Markets reduced its holdings in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 32.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,981 shares of the company's stock after selling 12,976 shares during th

Axonics, Inc. (NASDAQ:AXNX - Get Free Report) has received a consensus rating of "Hold" from the thirteen analysts that are presently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to t

Fifth Lane Capital LP acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 80,000 shares of the company's stoc

Tokio Marine Asset Management Co. Ltd. purchased a new stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 240,300 shares of the company's stock, valued at approximately $16,573,000. Axonics m

Principal Financial Group Inc. trimmed its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 39.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,447 shares of the compan

Goldman Sachs Group Inc. boosted its position in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 621,570 shares of the company's stock after purchasing an add

Axonics, Inc. (NASDAQ:AXNX - Get Free Report) has received an average recommendation of "Hold" from the thirteen analysts that are currently covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the

Osterweis Capital Management Inc. increased its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 69.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 103,614 shares of the company's stock after buying an additional 42,439 shares during the pe

Harbert Fund Advisors Inc. acquired a new stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 12,250 shares of the company's stock, valued at approximately $762,000. Several oth

Bellevue Group AG reduced its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 18.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,833,165 shares of the company's stock after selling 419,686 shares

Scout Investments Inc. purchased a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 94,127 shares of the company's stock, valued at approxima

Sectoral Asset Management Inc. cut its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 81.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 32,800 shares of the company's stock after selling 140,150 shares during the

Hsbc Holdings PLC increased its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 26.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 65,494 shares of the company's stock after acquiring an additional 13,734 shares during the period. Hsbc Hold

Norges Bank acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 604,931 shares of the company's stock, valued at approximately $37,645,000. Norges Bank owned

Artisan Partners Limited Partnership lifted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 91.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,220,889 shares of the company's stock after purchasing an additional 58

Dimensional Fund Advisors LP raised its position in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 922,295 shares of the company's stock after purchasing an additional 56,

BNP Paribas Financial Markets reduced its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 34.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,957 shares of the company's stock after sell

Axonics, Inc. (NASDAQ:AXNX - Get Free Report) has been assigned a consensus rating of "Hold" from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to

International Assets Investment Management LLC acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 13,131 shares of the company's stock, valued at approximate

Swiss National Bank lessened its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 10.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 99,400 shares of the company's stock after sell

Axonics, Inc. (NASDAQ:AXNX - Get Free Report) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 3,410,000 shares, a decrease of 15.6% from the April 15th total of 4,040,000 shares. Based on an average daily volume of 826,100 shares, the short-interest ratio is presently 4.1 days.

Russell Investments Group Ltd. lifted its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 1,144,500.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 91,568 shares of the company's stock a

Lisanti Capital Growth LLC lifted its holdings in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 41.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,950 shares of the company's stock afte

Needham & Company LLC reissued a "hold" rating on shares of Axonics in a report on Monday.

Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.

New York State Common Retirement Fund boosted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 28.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 158,657 shares of the company's stock after purchasi

Axonics (NASDAQ:AXNX - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.32). Axonics had a negative return on equity of 1.00% and a negative net margin of 1.66%. The business had revenue of $91.41 million during the quarter, compared to analysts' expectations of $89.79 million. During the same quarter in the prior year, the firm earned ($0.19) earnings per share. Axonics's quarterly revenue was up 29.4% on a year-over-year basis.

Axonics, Inc. (NASDAQ:AXNX - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 4,040,000 shares, a growth of 17.4% from the March 31st total of 3,440,000 shares. Based on an average trading volume of 919,900 shares, the short-interest ratio is presently 4.4 days.

Jennison Associates LLC boosted its holdings in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 56.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 354,331 shares of the company's stock after acquiring an ad

International Assets Investment Management LLC acquired a new stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 13,131 shares of the company's stock, valued at approxim

Calamos Advisors LLC acquired a new stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 60,694 shares of the company's stock, valued at approximately $3,7

Axonics, Inc. (NASDAQ:AXNX - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 3,440,000 shares, a growth of 17.0% from the March 15th total of 2,940,000 shares. Based on an average daily volume of 1,390,000 shares, the days-to-cover ratio is presently 2.5 days.

Impax Asset Management Group plc lifted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 244,525 shares of the company's stock afte

Peregrine Capital Management LLC cut its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 14.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 169,629 shares of the

Axonics (NASDAQ:AXNX) Shares Gap Down to $69.65

Shares of Axonics, Inc. (NASDAQ:AXNX - Get Free Report) have earned an average rating of "Hold" from the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and five have assigned a buy recommendat